In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis
Maximiliane Wußmann(Fraunhofer Institute for Silicate Research), Beate Rinner(Medical University of Graz)
Cited by 1